Priority Review
Priority Review
FDA review category for drugs that appear to represent an advance over available therapy; an NDA or BLA receives a faster review than standard applications.
FDA review category for drugs that appear to represent an advance over available therapy; an NDA or BLA receives a faster review than standard applications.